Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Maintains Overweight on ESAB, Lowers Price Target to $125

Author: Benzinga Newsdesk | August 07, 2025 03:50pm
JP Morgan analyst Tami Zakaria maintains ESAB (NYSE:ESAB) with a Overweight and lowers the price target from $137 to $125.

Posted In: ESAB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist